This study will evaluate the mechanism of action of thalidomide to selectively inhibit release of tumor necrosis factor (TNF) in patients with tuberculosis and/or HIV infection. It will assess the safety and efficacy of thalidomide, as judged by symptoms, physical examination, and studies of microbiological, immunologic, hematological, renal and hepatic status.
Showing the most recent 10 out of 470 publications